Induction of ovulation in seasonally anestrous mares under ambient lights using recombinant equine FSH (reFSH)

• Published in: Theriogenology Vol. 80; no. 5; pp. 456 - 462
• Main Authors: Meyers-Brown, Geraldine A., McCue, Patrick M., Troedsson, Mats H.T., Klein, Claudia, Zent, Walter, Ferris, Ryan A., Lindholm, Alicia R.G., Scofield, David B., Claes, Anthony N., Morganti, Monica, Colgin, Mark A., Wetzel, Robert L., Peters, Andrew R., Roser, Janet F.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.09.2013
• Subjects: Ambient lights; Anestrous mares; Anestrus - drug effects; Animals; blood; Female; Follicle Stimulating Hormone - administration & dosage; Follicle Stimulating Hormone - pharmacology; follicle-stimulating hormone; follicular development; horse breeds; Horses - physiology; human chorionic gonadotropin; luteinizing hormone; mares; ovarian follicles; Ovulation; Ovulation Induction - methods; Ovulation Induction - veterinary; periodicity; Photoperiod; Phototherapy; progesterone; Progesterone - blood; Recombinant equine FSH; Recombinant Fusion Proteins - pharmacology; Seasons; ultrasonography; Colorado; Kentucky; California; Ambient lights; Anestrous mares; Ovulation; Recombinant equine FSH
• ISSN: 0093-691X; 1879-3231
• DOI: 10.1016/j.theriogenology.2013.04.029

Traditionally, mares are put under artificial lights to advance the first ovulation of the year. The aim of the present study was to determine the efficacy of recombinant equine FSH (reFSH) in stimulating follicular development and advancing the first ovulation of the year in seasonally anestrous mares compared with anestrous mares given a placebo. Both groups of mares were housed under ambient light conditions. Sixty deep anestrous mares of light horse breeds (follicular diameters ≤20 mm in diameter and progesterone <1 ng/mL) were maintained under a natural photoperiod at three different sites: University of California, Davis, Colorado State University, and University of Kentucky Gluck Centre. Twenty mares at each site were randomly allocated to receive either 0.65 mg of reFSH (group A: treatment; n = 10) or a placebo (group B: control; n = 10) twice daily by im beginning on January 31. Treatment continued until one or more preovulatory follicles developed or up to a maximum of 15 days. Randomized treatments were blinded. Follicular development was closely monitored by transrectal ultrasonography. When the largest follicle reached ≥35 mm in diameter, reFSH treatment was discontinued and an injection of 2500 international units of hCG was administered iv 36 hours later to induce ovulation. Jugular blood samples were collected daily from all mares at University of California, Davis, and processed for LH, FSH, progesterone, estradiol-17β, and immunoreactive-inhibin by RIA. All 30 mares receiving reFSH (group A) developed follicles ≥35 mm within 7.4 ± 1.6 days of treatment. Twenty-three of the 30 reFSH-treated mares (group A) ovulated within 72 hours after hCG administration. In contrast, mares in group B (placebo, control) did not exhibit significant follicular development and none ovulated within the 15-day observation period. Mares in group A had significantly higher plasma levels of FSH, estradiol-17β, and immunoreactive-inhibin during treatment but did not exhibit a preovulatory LH surge. Mares administered reFSH returned to anestrus and spontaneously ovulated at a similar calendar date as control mares. These data indicate that reFSH was effective in stimulating the development of ovarian follicles and advancing the first ovulation of the year in seasonally anestrous mares under ambient lights but was not successful in inducing continued cyclicity.